Details for Luxembourg Supplementary Protection Certificate: 93315
✉ Email this page to a colleague
Luxembourg Supplementary Protection Certificate: 93315
Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 1539200 | 93315 | Luxembourg | PRODUCT NAME: PROCEDE DE TRAITEMENT DE LA SCLEROSE MULTIPLE - DACLIZUMAB; AUTHORISATION NUMBER AND DATE: EU/1/16/1107 | ⤷ Try a Trial |
>Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |